biote Corp.
BTMDNASDAQHealthcareMedical Care Facilities
As of Oct 16, 2026 close
- Market cap
- $31.78M
- P/E (TTM)
- 5.43
- Forward P/E
- 12.53
- Dividend yield
- -
- 52-week range
- $1.00$3.26
- Volume (live)
- -
- Avg. volume (3M)
- 126.90K
biote (BTMD) Stock Price & Financial Analysis
biote Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.08 - $1.14 |
|---|---|
| 52-Week High | $3.26 |
| 52-Week Low | $1.00 |
| Open | $1.10 |
| Volume (last close) | 41.59K |
| Average Volume (3M) | 126.90K |
| Revenue (TTM) | 183.53M |
|---|---|
| Net Income (TTM) | 5.86M |
| Free Cash Flow (TTM) | 18.88M |
| EPS (TTM) | $0.18 |
| Profit Margin | 3.19% |
| Operating Margin | 8.04% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 31.78M |
|---|---|
| Shares Outstanding | 28.63M |
| P/E Ratio (TTM) | 5.43 |
| Forward P/E | 12.53 |
| Price to Sales (P/S) | 0.17 |
| Price to Book (P/B) | -0.48 |
| EV/EBITDA | 4.65 |
| 50-Day MA | $1.40 |
|---|---|
| 200-Day MA | $1.91 |
| 1-Year Change | −60.92% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
biote at a Glance
As of the Oct 16, 2026 close, biote (BTMD) has a market capitalization of $31.78M. The stock trades at 5.4× trailing earnings, 12.5× forward earnings and 0.2× sales. Over the trailing twelve months it earned $5.86M on revenue of $183.53M (a 3.2% profit margin) and generated $18.88M of free cash flow. Revenue fell 7.8% year over year.
As of its latest reported balance sheet, it holds $11.17M in cash and securities against $121.50M of debt, a net debt position of $110.33M.
biote does not currently pay a dividend.
The share price is down 60.9% over the past year. At $1.08 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.00 to $3.26, below its 200-day moving average of $1.91.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $2.00, 84.3% above the Oct 16, 2026 close.
Frequently Asked Questions About biote
What is the current stock price for BTMD?
As of the Oct 16, 2026 close, BTMD stock trades at $1.08. The 52-week range is $1.00–$3.26, with a day range of $1.08–$1.14.
What is the P/E ratio for BTMD?
As of the Oct 16, 2026 close, biote's trailing twelve-month (TTM) P/E ratio is 5.4, meaning investors pay $5.4 for every $1 of annual earnings. The forward P/E is 12.5, reflecting analyst expectations for future earnings. biote operates in the Healthcare sector.
Does BTMD pay dividends?
biote does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BTMD?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for BTMD is Buy. The average 12-month price target is $2.00, a 84.3% upside from the Oct 16, 2026 close of $1.08.
What is the market cap of BTMD?
As of the Oct 16, 2026 close, biote's market capitalization is $31.1M, classifying it as a micro-cap company. biote operates in the Healthcare sector within the Medical Care Facilities industry.